home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505d.zip
/
M9550892.TXT
< prev
next >
Wrap
Text File
|
1995-03-25
|
2KB
|
28 lines
Document 0892
DOCN M9550892
TI Mononuclear cell adoptive immunotherapy.
DT 9505
AU Lee JH; Klein HG; Department of Transfusion Medicine, Warren G. Magnuson
Clinical; Center, National Institutes of Health, Bethesda, Maryland.
SO Hematol Oncol Clin North Am. 1994 Dec;8(6):1203-21. Unique Identifier :
AIDSLINE MED/95164347
AB In contrast with red cells, platelets, and granulocytes, hemotherapy
using lymphocytes and monocytes is only beginning to be explored. Blood
banks and transfusion services, the traditional sources of expertise in
sterile cell processing, storage, and transfusion, have played an
integral role in the early technical development of mononuclear cell
adoptive immunotherapy, and are logical partners in its future. This
article reviews the clinical experience with this novel transfusion
therapy.
DE Abortion, Habitual/THERAPY Diabetes Mellitus, Insulin-Dependent/THERAPY
Female Graft vs Host Reaction Herpesvirus 4, Human Human HIV
Infections/THERAPY *Immunotherapy, Adoptive Killer Cells,
Lymphokine-Activated Leukemia/THERAPY *Leukocytes, Mononuclear
Lymphocytes, Tumor-Infiltrating Lymphoproliferative
Disorders/THERAPY/VIROLOGY Pregnancy JOURNAL ARTICLE REVIEW REVIEW,
TUTORIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).